Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Phagenesis

More Like This

PR Newswire associated0

Phagenesis Appoints Stephen Oesterle, MD, to Board of Directors

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

PR Newswire associated0

Pharyngeal Electrical Stimulation Recognized as Important Tool for Post-Stroke Recovery in New American Heart Association and American Stroke Association Guideline

Chad Swanson, Ph.D., Chief Development Officer, Prothena (Photo: Business Wire)

Prothena Announces Leadership Team Updates

Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion

PR Newswire associated0

EXPANSE MEDICAL WELCOMES JEFF HOPKINS AS CEO AND BOARD MEMBER OF ITS SPIN-OFF, FLOWPHYSIX

PR Newswire associated0

Axon Therapies Raises $32M in Oversubscribed Series A to Transform Heart Failure Treatment

Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea